GSK3B and Alzheimer disease: Certain probiotics have the potential of suppressing AD-related GSK3B overexpression, by modulating the PI3K/Akt signaling pathways in the gut or indirectly through metabolites and SCFAs to provide changes in the gut and brain [227,228,229].